Cat. No. Name Size Price Add Cart
KI0712Niclosamide100 mg$272

Chemical Characteristic

Product NameNiclosamide
SynonymsNiclocide, Yomesan, Bayluscide
CAS No.50-65-7
Molecular Weight 327.12
FormulaC13H8Cl2N2O4
Chemical Structure

Biological activities

Niclosamide is effective as a virus replication inhibitor. Niclosamide is an antihelminthic drug and has been used to treat tapeworm. [1] Niclosamide is a potent inducer of LC3-positive autophagosomes, an inhibitor of the Wnt/Frizzled pathway, a suppressor of the autonomous notch-signalling pathway, and an inhibitor of mTOR signaling. [2] Niclosamide is a unique small molecule Wnt/β-catenin signaling inhibitor targeting the Wnt co-receptor LRP6 on the cell surface. [3] Niclosamide inhibits replication of a newly discovered coronavirus, SARS-CoV. Niclosamide inhibits viral antigen synthesis with an IC50 ranging from 1 to 3 µM. [1]Niclosamide effectively inhibits influenza virus (strain A/Puerto Rico/8/34/H1N1 depicted PR8) with an IC50 of 0.83 µM in human lung adenocarcinoma epithelial A549 cells. Niclosamide is also an effective antiviral in non-transformed cells, including WI-38 human embryonic diploid airway cells infected with HRV1A, with an IC50 of 1.3 µM. [2] Niclosamide suppresses LRP6 expression and phosphorylation, blocks Wnt3A-induced β-catenin accumulation, and inhibits Wnt/β-catenin signaling in HEK293 cells. Niclosamide induces cancer cell apoptosis, and displays excellent anticancer activity with IC50 less than 1 µM for prostate PC-3 and DU145, breast MDA-MB-231 and T-47D cancer cells. [3] Niclosamide promotes Frizzled1 endocytosis, down-regulates Dishevelled-2 protein, and inhibits Wnt3A-stimulated β-catenin stabilization and LEF/TCF reporter activity. Niclosamide inhibits Wnt/Frizzled signaling induced by a full agonist, with an IC50 of 0.5 µM. [4] Niclosamide inhibits the transcription and DNA binding of NF-κB. Niclosamide blocks tumor necrosis factor-induced IκBα phosphorylation, translocation of p65, and expression of NF-κB-regulated genes. Niclosamide inhibits the steps TAK1閳墳κB kinase (IKK) and IKK閳墳κBα. Niclosamide also increases the levels of reactive oxygen species (ROS) in acute myelogenous leukemia (AML) cells. [5] Niclosamide decreases downstream β-catenin signaling and exerts anti-proliferative effects in human colon cancer cell lines and colorectal cancer cells isolated by surgical resection of metastatic disease, regardless of mutations in adenomatous polyposis coli (APC). [6] Niclosamide inhibits growth of xenografted AML cells in nude mice. [5] Niclosamide inhibits the growth of human colorectal cancers (CRCs) in NOD/SCID mice. [6]

Protocols

Niclosamide is prepared as a 10 mM stock solution in DMSO. [1]

References

[1] Wu CJ, et al. Inhibition of severe acute respiratory syndrome coronavirus replication by niclosamide. Antimicrob Agents Chemother. 2004, 48(7): 2693-2696. 閵嗏偓閵嗏偓
[2] Jurgeit A, et al. Niclosamide is a proton carrier and targets acidic endosomes with broad antiviral effects. PLoS Pathog. 2012, 8(10): e1002976. 閵嗏偓閵嗏偓
[3] Lu W, et al. Niclosamide suppresses cancer cell growth by inducing Wnt co-receptor LRP6 degradation and inhibiting the Wnt/β-catenin pathway. PLoS One. 2011, 6(12): e29290. 閵嗏偓閵嗏偓
[4] Chen M, et al. The anti-helminthic niclosamide inhibits Wnt/Frizzled1 signaling. Biochemistry. 2009, 48(43): 10267-10274. 閵嗏偓閵嗏偓
[5] Jin Y, et al. Antineoplastic mechanisms of niclosamide in acute myelogenous leukemia stem cells: inactivation of the NF-kappaB pathway and generation of reactive oxygen species. Cancer Res. 2010, 70(6): 2516-2527. 閵嗏偓閵嗏偓
[6] Osada T, et al. Antihelminth compound niclosamide downregulates Wnt signaling and elicits antitumor responses in tumors with activating APC mutations. Cancer Res. 2011, 71(12): 4172-4182. 閵嗏偓閵嗏偓

Please click here to fill online order form, and we will make sure to supply you product with detail information. This process usually takes between 24 to 48 hours, depending on products stock avaliability. All inquires and subsequent projects are handled in the strictest confidence and will be backed by a confidentiality agreement if required.
KareBayTM provides scientists and clinicians with a wide range of biotechnological products and science lab supplies for chemical research and analyzing life processes. KareBay's extensive capabilities include commercializing reagents and kits, manufacturing biotech products and providing contract research services to organizations worldwide. Our many global labs, offices, and business partners enable KareBay to extend its products and services to its customer base around the world.

Our products are used for research, laboratory and further evaluation purposes. They are not for human use.